Omega-3 fatty acids' supplementation in Alzheimer's disease: A systematic review - PubMed (original) (raw)

Omega-3 fatty acids' supplementation in Alzheimer's disease: A systematic review

Scheine Canhada et al. Nutr Neurosci. 2018 Oct.

Abstract

Introduction: Alzheimer's disease (AD) is a neurodegeneration disorder characterized by progressive impairments of memory, language, reasoning, and other cognitive functions. Evidence suggests that omega-3 fatty acids may act as a possible protection factor in AD.

Objective: To evaluate the results available in the literature involving omega-3 fatty acids supplementation and its effect on cognitive function in AD patients.

Methods: A systematic review of MEDLINE (from PubMed), Excerpta Medica Database, and Cochrane Library databases was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Inclusion criteria consisted in original intervention studies, controlled by placebo, that assessed the impact of supplementation or dietary intake of omega-3 fatty acids on cognitive function, in humans with AD, without limitation for prime date of publication.

Results: Initial search resulted in 361 articles. Seven studies fully met the inclusion criteria. Most studies did not find statistically significant results for the omega-3 fatty acids supplementation compared to placebo, and those who show some benefit do it only in a few cognitive assessment scales. However, the effects of omega-3 fatty acids appear to be most effectively demonstrated in patients with very mild AD.

Conclusion: The effects of omega-3 fatty acids supplementation in mild AD corroborate epidemiological observational studies showing that omega-3 fatty acids may be beneficial in disease onset, when there is slight impairment of brain function. Although some studies have shown changes in scales of cognitive function in more severe cases, they are not enough to support omega-3 fatty acids supplementation in the treatment of AD.

Keywords: Alzheimer's disease; Cognition; Docosahexaenoic acid; Eicosapentaenoic acid; Neuroinflammation; Omega-3 fatty acids.

PubMed Disclaimer

Cited by

Update on Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Health.
Rodriguez D, Lavie CJ, Elagizi A, Milani RV. Rodriguez D, et al. Nutrients. 2022 Dec 3;14(23):5146. doi: 10.3390/nu14235146. Nutrients. 2022. PMID: 36501174 Free PMC article. Review.
Effects of preventive interventions on neuroimaging biomarkers in subjects at-risk to develop Alzheimer's disease: A systematic review.
Perus L, Busto GU, Mangin JF, Le Bars E, Gabelle A. Perus L, et al. Front Aging Neurosci. 2022 Nov 24;14:1014559. doi: 10.3389/fnagi.2022.1014559. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36506466 Free PMC article.
Structured Long-Chain Omega-3 Fatty Acids for Improvement of Cognitive Function during Aging.
Mora I, Arola L, Caimari A, Escoté X, Puiggròs F. Mora I, et al. Int J Mol Sci. 2022 Mar 23;23(7):3472. doi: 10.3390/ijms23073472. Int J Mol Sci. 2022. PMID: 35408832 Free PMC article. Review.
The potential role of nutritional components in improving brain function among patients with Alzheimers disease: a meta-analysis of RCT studies.
Albrahim T. Albrahim T. Neurosciences (Riyadh). 2020 Jan;25(1):4-17. doi: 10.17712/nsj.2020.1.20190037. Neurosciences (Riyadh). 2020. PMID: 31982903 Free PMC article.
Argan Oil-Mediated Attenuation of Organelle Dysfunction, Oxidative Stress and Cell Death Induced by 7-Ketocholesterol in Murine Oligodendrocytes 158N.
Badreddine A, Zarrouk A, Karym EM, Debbabi M, Nury T, Meddeb W, Sghaier R, Bezine M, Vejux A, Martine L, Grégoire S, Bretillon L, Prost-Camus E, Durand P, Prost M, Moreau T, Cherkaoui-Malki M, Nasser B, Lizard G. Badreddine A, et al. Int J Mol Sci. 2017 Oct 23;18(10):2220. doi: 10.3390/ijms18102220. Int J Mol Sci. 2017. PMID: 29065513 Free PMC article.

Omega-3 fatty acids' supplementation in Alzheimer's disease: A systematic review - PubMed (original) (raw)